Sotera Health Co SHC
We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. 10-K, Item 1
- Employees
- 3,000
- Headquarters
- Broadview Heights, OH
- CEO
- Alton Shader
- Next results
- around Jan 11, 2027
Where each dollar of revenue went, FY2025
Revenue of $1.2B through the costs to a net profit of $77.9M · income statement of the 10-K
SHC among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
5 new risk paragraphs and 1 accounting fact worth reading about. 10-K filed Feb 24, 2026 against Feb 27, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
1fact worth reading about the other 10 checks found nothing to note
-
Critical audit matters changedNew this year: Valuation of Goodwill (“As disclosed in Note 7 to the consolidated financial statements, at December 31, 2025, the Company reported $1.1 billion of goodwill. As explained in Note 1 to the consolidated financial statements, goodwill is tested for impairment annually as of October 1. Management performed a quantitative impai”). No longer listed: Valuation of Nelson Labs Reporting Unit Goodwill
-
Receivables -0.7% ($140.3M to $139.3M) vs revenue +5.7% ($1.1B to $1.2B), -6.5 pts apart
9 more checks with nothing to note
-
Cash from operations $287.2M vs net income $77.9M (FY ending Dec 31, 2025)
-
Inventory +10.6% ($49.2M to $54.4M) vs revenue +5.7% ($1.1B to $1.2B), +4.9 pts apart
-
Same auditor in both 10-Ks: Ernst & Young LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
5 paragraphs in Risk Factors that were not in the 10-K filed Feb 27, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
Despite the Company’s security measures, cybersecurity threats, cybersecurity incidents, outages, malfunctions, or disruptions involving our systems or those of our third party business partners, or any failure by us or our third-party business partners to
-
Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
We may be incorporating AI technologies into our products, services and processes, which may present business, compliance and reputational risks. The introduction of AI and machine-learning technologies, into internal processes, third-party services and/or new and existing offerings may result in new or expanded risks and liabilities,…
-
Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
As of December 31, 2025, our total indebtedness was approximately $2,169.5 million, all of which is indebtedness of our subsidiary Sotera Health Holdings, LLC (“SHH”) that is guaranteed by the Company and certain of our other subsidiaries.
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.1B | $1.2B |
| Net income | −$233.6M | $51.4M | $44.4M | $77.9M |
| Operating cash flow | $278.0M | −$147.7M | $224.2M | $287.2M |
| Free cash flow | $95.6M | −$362.7M | $45.1M | $149.2M |
Revenue, FY2019 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$1.2B ▲ 5.7% in FY2025$77.9M ▲ 75.6% in FY2025$149.2M ▲ 230.8% in FY2025
Recent filings
2 filings in the last 30 days · SEC EDGAR
-
8-KNov 3, 2026Quarterly results 8-K item 2.02
-
10-QNov 3, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Sotera Health Co, Broadview Heights, OH · from the 10-K filed Feb 24, 2026
We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. We are driven by our mission: Safeguarding Global Health®. We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world. In 2025, our customers included over 40 of the top 50 medical device companies and nine of the top ten global pharmaceutical companies (based on revenue).
- Headquarters
- Broadview Heights, OH
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Nov 3, 2026
- Incorporated in
- DE
Employees, at the top of the page: "Across our 62 facilities worldwide, we have over 3,000 employees who are dedicated to safety and quality" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 27, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SHC/export.csv") into a cell.